trans-2,5-Dimethylpyrrolidine hydrochloride

Catalog No.: 
ACZGWB350
CAS No.: 
114143-75-8
Molecular Formula: 
C6H14ClN
Molecular Weight: 
135.64
trans-2,5-Dimethylpyrrolidine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$82.00In stockInquiry
250mg95%$133.00In stockInquiry
1g95%$319.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametrans-2,5-Dimethylpyrrolidine hydrochloride
IUPAC Name(2R,5R)-2,5-dimethylpyrrolidine hydrochloride
MDL No.MFCD01249058
Molecular FormulaC6H14ClN
Molecular Weight135.64
SMILESC[C@@H]1CC[C@@H](C)N1.[H]Cl
InChI KeyAFHNFHHYTYQLIO-KGZKBUQUSA-N
Synonymrac trans-2,5-Dimethylpyrrolidine x HCl, 98%;(trans)-2,5-dimethylpyrrolidine hydrochloride;Pyrrolidine, 2,5-dimethyl-, hydrochloride, (2R,5R)-rel-;rel-(2R,5R)-2,5-Dimethylpyrrolidine hydrochloride;rac trans-2,5-Dimethylpyrrolidine x;Pyrrolidine, 2,5-dimethyl-, hydrochloride (1:1), (2R,5R)-rel-
CAS No.114143-75-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACZGWB350 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZGWB350 route product structure diagram
    ACZGWB350114143-75-8In Stock
Inquiry

2. ACZGWB350 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZGWB350 route product structure diagram
    ACZGWB350114143-75-8In Stock
Inquiry

3. ACZGWB350 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZGWB350 route product structure diagram
    ACZGWB350114143-75-8In Stock
Inquiry

Comments (0)